A

Amerisourcebergen Corp
LSE:0HF3

Watchlist Manager
Amerisourcebergen Corp
LSE:0HF3
Watchlist
Price: 249.24 USD -0.59% Market Closed
Market Cap: 51.7B USD
Have any thoughts about
Amerisourcebergen Corp?
Write Note

Net Margin
Amerisourcebergen Corp

0.5%
Current
1%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.5%
=
Net Income
1.5B
/
Revenue
294B

Net Margin Across Competitors

Country US
Market Cap 48.9B USD
Net Margin
1%
Country US
Market Cap 77.7B USD
Net Margin
1%
Country US
Market Cap 48.4B USD
Net Margin
1%
Country US
Market Cap 30.1B USD
Net Margin
1%
Country US
Market Cap 9.3B USD
Net Margin
3%
Country CN
Market Cap 65B CNY
Net Margin
8%
Country KR
Market Cap 12.2T KRW
Net Margin
7%
Country CN
Market Cap 65.4B HKD
Net Margin
1%
Country CN
Market Cap 60.9B CNY
Net Margin
1%
Country IT
Market Cap 5.5B EUR
Net Margin
7%
Country DE
Market Cap 5B EUR
Net Margin
-5%
No Stocks Found

Amerisourcebergen Corp
Glance View

Market Cap
48.6B USD
Industry
Health Care
Economic Moat
None

AmerisourceBergen Corp. is a leading healthcare services company that plays an essential role in the pharmaceutical supply chain, connecting manufacturers, healthcare providers, and patients. Founded in 2001 and headquartered in Chesterbrook, Pennsylvania, the company has grown through strategic acquisitions and an unwavering commitment to improving patient access to critical medications. AmerisourceBergen stands out by providing a wide range of services, including drug distribution, specialty pharmacy solutions, and healthcare consulting, making it a vital partner for thousands of healthcare organizations across the United States and beyond. By prioritizing innovation and efficiency, they not only streamline pharmaceutical delivery but also enhance patient care in an increasingly complex healthcare landscape. As investors consider AmerisourceBergen, they can take comfort in the company’s impressive financial performance and resilience against market fluctuations. With a robust revenue stream primarily generated from the distribution of pharmaceuticals, AmerisourceBergen benefits from the growing demand for healthcare products and services. Additionally, the company's strategic partnerships and investment in technology position it well for future growth, particularly in the specialty drug sector, which is expanding rapidly due to the rise of biologics and personalized medicine. AmerisourceBergen's focus on operational excellence and customer satisfaction not only fosters loyalty among its clients but also supports a stable and attractive investment outlook, making it a compelling option for those looking to capitalize on the evolving healthcare market.

0HF3 Intrinsic Value
454.17 USD
Undervaluation 45%
Intrinsic Value
Price
A

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.5%
=
Net Income
1.5B
/
Revenue
294B
What is the Net Margin of Amerisourcebergen Corp?

Based on Amerisourcebergen Corp's most recent financial statements, the company has Net Margin of 0.5%.